Icahn School of Medicine is a clinical research site located in New York, New York, United States 10029.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Icahn School of Medicine has participated in 14 clinical trials with 2 currently active.
Therapeutic areas: Clinically Isolated Syndrome, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.
Sponsors: Icahn School of Medicine at Mount Sinai, Pacira Pharmaceuticals, Inc, Ultragenyx Pharmaceutical Inc.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Icahn School of Medicine has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Icahn School of Medicine has 14 clinical trials on record, with 2 currently active. Their work covers Clinically Isolated Syndrome, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.
Yes — Icahn School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.